Overview Dividends

(CHD) Church & Dwight - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1713401024

Baking Soda, Laundry Detergent, Toothpaste, Condoms, Supplements

CHD EPS (Earnings per Share)

EPS Growth (3Y CAGR): 10.21%
EPS Trend (3Y Correlation): -1.6%

CHD Revenue

Revenue Growth (3Y CAGR): 3.67%
Revenue Trend (3Y Correlation): 74.0%

Risk via 10d forecast
Volatility	21.1%
Value at Risk 5%th	35.7%

Reward
Sharpe Ratio	-1.10
Alpha Jensen	-28.21

Character
Hurst Exponent	0.454
Beta	0.452

Drawdowns 3y
Max DD	27.28%
Mean DD	6.45%

Description: CHD Church & Dwight October 16, 2025

Church & Dwight Co. (NYSE: CHD) manufactures and markets a diversified portfolio of household, personal-care, and specialty products across three operating segments-Consumer Domestic, Consumer International, and Specialty Products. Its flagship ARM & HAMMER line spans baking-soda-based cleaners, cat litter, and laundry detergents, while the TROJAN brand dominates the condom market and OXICLEAN supplies stain-removing solutions. The company also sells niche health-care items (e.g., FIRST RESPONSE pregnancy tests) and animal-nutrition additives such as BIO-CHLOR and CERTILLUS.

In FY 2023 the firm reported revenue of roughly $5.5 billion, with the ARM & HAMMER household segment contributing about 55 % of sales and delivering an operating margin near 17 %. Net income grew 8 % year-over-year, reflecting modest pricing power in a high-inflation environment and cost-saving initiatives in its supply chain. The specialty animal-feed division, though only ~5 % of total revenue, has a higher gross margin (≈30 %) and benefits from rising protein-demand in emerging markets-a key sector driver.

CHD’s distribution model blends traditional brick-and-mortar channels (supermarkets, mass merchandisers, drugstores) with expanding e-commerce platforms, a trend that has accelerated post-COVID and now accounts for roughly 12 % of total sales. Assuming continued consumer-goods inflation stays within the 3-4 % range, the company’s pricing elasticity suggests earnings could sustain a 5-6 % annual growth rate, but a slowdown in discretionary spending would materially pressure margins.

For a deeper dive into CHD’s valuation metrics and scenario analysis, the ValueRay platform offers a concise, data-driven overview.

CHD Stock Overview

Market Cap in USD	20,325m
Sub-Industry	Household Products
IPO / Inception	1986-03-06
Return 12m vs S&P 500	-31.0%
Analyst Rating	3.42 of 5

CHD Dividends

Dividend Yield	1.37%
Yield on Cost 5y	1.41%
Yield CAGR 5y	4.30%
Payout Consistency	92.0%
Payout Ratio	34.4%

CHD Growth Ratios

CAGR	5.45%
CAGR/Max DD Calmar Ratio	0.20
CAGR/Mean DD Pain Ratio	0.84
Current Volume	2113.5k
Average Volume	2139.8k

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (782.5m TTM) > 0 and > 6% of Revenue (6% = 368.5m TTM)

FCFTA 0.11 (>2.0%) and ΔFCFTA 1.12pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 2.11% (prev 12.72%; Δ -10.61pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.13 (>3.0%) and CFO 1.14b > Net Income 782.5m (YES >=105%, WARN >=100%)

Net Debt (2.07b) to EBITDA (1.33b) ratio: 1.55 <= 3.0 (WARN <= 3.5)

Current Ratio 1.09 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (245.9m) change vs 12m ago 0.53% (target <= -2.0% for YES)

Gross Margin 44.44% (prev 45.65%; Δ -1.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 68.96% (prev 69.85%; Δ -0.89pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 9.30 (EBITDA TTM 1.33b / Interest Expense TTM 117.0m) >= 6 (WARN >= 3)

Altman Z'' 4.79

(A) 0.01 = (Total Current Assets 1.63b - Total Current Liabilities 1.50b) / Total Assets 9.14b

(B) 0.73 = Retained Earnings (Balance) 6.70b / Total Assets 9.14b

(D) 1.42 = Book Value of Equity 6.97b / Total Liabilities 4.92b

Total Rating: 4.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 74.62

1. Piotroski 6.0pt = 1.0

2. FCF Yield 4.57% = 2.28

3. FCF Margin 16.65% = 4.16

4. Debt/Equity 0.56 = 2.35

5. Debt/Ebitda 1.55 = 0.87

6. ROIC - WACC (= 5.60)% = 7.00

7. RoE 17.86% = 1.49

8. Rev. Trend 73.99% = 5.55

9. EPS Trend -1.58% = -0.08

What is the price of CHD shares?

As of November 13, 2025, the stock is trading at USD 85.38 with a total of 2,113,498 shares traded.
Over the past week, the price has changed by -1.49%, over one month by -1.32%, over three months by -7.15% and over the past year by -20.00%.

Is Church & Dwight a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Church & Dwight (NYSE:CHD) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 74.62 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CHD is around 73.76 USD . This means that CHD is currently overvalued and has a potential downside of -13.61%.

Is CHD a buy, sell or hold?

Church & Dwight has received a consensus analysts rating of 3.42. Therefor, it is recommend to hold CHD.

Strong Buy: 7
Buy: 2
Hold: 10
Sell: 4
Strong Sell: 1

What are the forecasts/targets for the CHD price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	97	13.6%
Analysts Target Price	97	13.6%
ValueRay Target Price	81.2	-4.9%

CHD Fundamental Data Overview November 11, 2025

Market Cap USD = 20.32b (20.32b USD * 1.0 USD.USD)
P/E Trailing = 26.7003
P/E Forward = 22.4719
P/S = 3.3097
P/B = 4.8128
P/EG = 1.9523
Beta = 0.452
Revenue TTM = 6.14b USD
EBIT TTM = 1.09b USD
EBITDA TTM = 1.33b USD
Long Term Debt = 2.20b USD (from longTermDebt, last fiscal year)
Short Term Debt = 32.4m USD (from shortTermDebt, last fiscal year)
Debt = 2.37b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.07b USD (from netDebt column, last quarter)
Enterprise Value = 22.39b USD (20.32b + Debt 2.37b - CCE 305.3m)
Interest Coverage Ratio = 9.30 (Ebit TTM 1.09b / Interest Expense TTM 117.0m)
FCF Yield = 4.57% (FCF TTM 1.02b / Enterprise Value 22.39b)
FCF Margin = 16.65% (FCF TTM 1.02b / Revenue TTM 6.14b)
Net Margin = 12.74% (Net Income TTM 782.5m / Revenue TTM 6.14b)
Gross Margin = 44.44% ((Revenue TTM 6.14b - Cost of Revenue TTM 3.41b) / Revenue TTM)
Gross Margin QoQ = 45.06% (prev 42.95%)
Tobins Q-Ratio = 2.45 (Enterprise Value 22.39b / Total Assets 9.14b)
Interest Expense / Debt = 1.97% (Interest Expense 46.8m / Debt 2.37b)
Taxrate = 22.86% (54.0m / 236.2m)
NOPAT = 839.3m (EBIT 1.09b * (1 - 22.86%))
Current Ratio = 1.09 (Total Current Assets 1.63b / Total Current Liabilities 1.50b)
Debt / Equity = 0.56 (Debt 2.37b / totalStockholderEquity, last quarter 4.22b)
Debt / EBITDA = 1.55 (Net Debt 2.07b / EBITDA 1.33b)
Debt / FCF = 2.02 (Net Debt 2.07b / FCF TTM 1.02b)
Total Stockholder Equity = 4.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.56% (Net Income 782.5m / Total Assets 9.14b)
RoE = 17.86% (Net Income TTM 782.5m / Total Stockholder Equity 4.38b)
RoCE = 16.52% (EBIT 1.09b / Capital Employed (Equity 4.38b + L.T.Debt 2.20b))
RoIC = 12.64% (NOPAT 839.3m / Invested Capital 6.64b)
WACC = 7.04% (E(20.32b)/V(22.70b) * Re(7.68%) + D(2.37b)/V(22.70b) * Rd(1.97%) * (1-Tc(0.23)))
Discount Rate = 7.68% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.22%
[DCF Debug] Terminal Value 79.39% ; FCFE base≈962.4m ; Y1≈1.04b ; Y5≈1.29b
Fair Price DCF = 93.82 (DCF Value 22.53b / Shares Outstanding 240.1m; 5y FCF grow 9.21% → 3.0% )
EPS Correlation: -1.58 | EPS CAGR: 10.21% | SUE: 0.19 | # QB: 0
Revenue Correlation: 73.99 | Revenue CAGR: 3.67% | SUE: 2.21 | # QB: 1

Additional Sources for CHD Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle